Trailing-twelve-month (TTM) revenue is $21.95 Billion with a year-over-year growth of +6.74%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $5,175,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q2 FY2026Period ended 2025-12-31 | $5,359,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-29 |
| Q3 FY2026Period ended 2026-03-31 | $5,939,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q4 FY2026Period ended 2026-06-30 | $5,473,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $21,947,500,000 |
Current P/S: $106,441,169,520 market capitalization ÷ $21,947,500,000 TTM revenue = 4.85x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T18:10:25.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $5.47B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T18:10:25.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Global | $2.2B | $2.2B | $2.3B | $2.5B | $2.6B | $2.9B |
| HCM | $6.6B | $7.2B | $7.7B | $8.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| CANADA | $337M | $389M | $428M | $474M | $489M | $524M |
| Europe | $1.3B | $1.3B | $1.3B | $1.5B |
$21.95B
$21.95 Billion
+6.74%
vs. $20.56B a year ago (TTM)
+7.90%
5 Year compound annual growth rate
1 Year
+6.74%
3 Year
+6.81%
5 Year
+7.90%
10 Year
+6.87%
15 Year
+5.56%
20 Year
+4.49%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $21.95B | +$1.39B | +6.74% |
| 2025 | $20.56B | +$1.36B | +7.07% |
| 2024 | $19.20B | +$1.19B | +6.61% |
| 2023 | $18.01B | +$1.51B | +9.18% |
| 2022 | $16.50B | +$1.49B | +9.95% |
| 2021 |
TTM Growth
+6.74%
3-Year CAGR
+6.81%
5-Year CAGR
+7.90%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-10T18:10:25.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $9.1B |
| HRO | $2.7B | $3.1B | $3.4B | $3.5B | $3.8B | $4.0B |
|---|
| Interest on Funds Held for Clients | $422M | $452M | $813M | $1.0B | N/A | N/A |
|---|
| Professional Employee Organization Services Segment | $3.1B | $3.5B | $3.8B | $4.0B | $4.3B | $4.6B |
|---|
| N/A |
| Other Segments | $279M | $302M | $325M | $343M | $359M | $411M |
|---|
| UNITED STATES | $13.1B | $14.5B | $16.0B | $16.9B | $18.2B | $19.3B |
|---|
| $15.01B |
| +$415.60M |
| +2.85% |
| 2020 | $14.59B | +$414.60M | +2.92% |
| 2019 | $14.18B | +$847.50M | +6.36% |
| 2018 | $13.33B | +$947.90M | +7.66% |
| 2017 | $12.38B | +$712.00M | +6.10% |
